Discover 3,086 paid clinical trials in Worcester, Massachusetts. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,086
ctDNA in Cutaneous Squamous Cell Carcinoma
for
Cutaneous Squamous Cell Carcinoma
Location: Boston MA
Sponsor: Massachusetts Eye and Ear Infirmary
Sex: All
Age: 18+
Code: NCT06875609
Recruiting
Dose-Reduced Docetaxel With Cyclophosphamide for the Treatment of Vulnerable Older Women With Stage I-III HER2 Negative Breast Cancer, the DOROTHY Trial
for
Anatomic Stage I Breast Cancer AJCC v8,
Location: Boston MA, Rochester NY, Duarte CA
Sponsor: City of Hope Medical Center
Sex: All
Age: 65+
Code: NCT06042569
Phase 2, Recruiting
NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)
Location: Boston MA, New Haven CT, Durham NC, Chicago IL,
Sponsor: Miltenyi Biomedicine GmbH
Sex: All
Age: 18+
Code: NCT06116110
Recruiting
Open Label, Safety and Efficacy Study of QRX003 Lotion in Subjects With Netherton Syndrome
for
Netherton Syndrome
Location: Quincy MA, Indianapolis IN, San Diego CA
Sponsor: Quoin Pharmaceuticals
Sex: All
Age: 14+
Code: NCT05789056
Phase 2, Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Adolescent Outcomes of Post-operative Opioid EXposure
for
Opioid Use Disorder, Pain, Chronic
Location: Boston MA
Sponsor: Sharon Levy
Sex: All
Age: 12 - 17
Code: NCT06350409
Recruiting
Phase Ib Study of Axatilimab in Combination With Olaparib in BRCA1/2 and PALB2- Associated Metastatic HER2-negative Breast Cancer
for
Breast Cancer, PALB2-Mutated Breast Carcinoma,
Location: Boston MA, Rochester MN
Sponsor: Dana-Farber Cancer Institute
Sex: All
Age: 18+
Code: NCT06488378
Phase 1, Recruiting
CAP-100 for Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia
for
Lymphocytic Leukemia, Chronic, SLL
Location: Boston MA, Durham NC
Sponsor: Catapult Therapeutics
Sex: All
Age: 18+
Code: NCT04704323
Phase 1, Recruiting
First In Human Study of CX-2051 in Advanced Solid Tumors
for
Solid Tumor, Adult
Location: Boston MA, The Bronx NY, Fairfax VA, Huntersville NC,
Sponsor: CytomX Therapeutics
Sex: All
Age: 18+
Code: NCT06265688
Phase 1, Recruiting
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
for
AML, AML With Mutated NPM1, Hematologic Malignancy, KMT2Ar,
Location: Boston MA, New Haven CT, Stony Brook NY,
Sponsor: Kura Oncology, Inc.
Sex: All
Age: 18+
Code: NCT06001788
Phase 1, Recruiting
Implantable Microdevice In Primary Brain Tumors
for
Grade II Glioma, Grade III Glioma, Grade IV Glioma, Astrocytoma,
Location: Boston MA
Sponsor: Oliver Jonas
Sex: All
Age: 18+
Code: NCT04135807
Early Phase 1, Recruiting
Effects of Mother's Voice and Heartbeat Sounds on Preterm Newborns
for
Preterm Birth
Location: Boston MA
Sponsor: Brigham and Women's Hospital
Sex: All
Age: 0
Code: NCT01913288
Recruiting
A Personalized Neoantigen Cancer Vaccine in Treatment Naïve, Asymptomatic Patients With IGHV Unmutated CLL.
for
Lymphocytic Leukemia
Location: Boston MA
Sponsor: Dana-Farber Cancer Institute
Sex: All
Age: 18+
Code: NCT03219450
Phase 1, Recruiting
A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)
for
Graft-versus-host Disease (GVHD)
Location: Boston MA, New York NY, Philadelphia PA, Richmond VA,
Sponsor: Incyte Corporation
Sex: All
Age: 18+
Code: NCT06615050
Phase 3, Recruiting
A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors
for
Advanced Solid Tumors
Location: Boston MA, Toronto, Ann Arbor MI, Dallas TX, Houston TX,
Sponsor: LigaChem Biosciences, Inc.
Sex: All
Age: 18+
Code: NCT05941507
Phase 1, Phase 2, Recruiting
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
for
Ovarian Cancer
Location: Boston MA, Paramus NJ, New York NY, Bethlehem PA,